A Telephone-delievered Intervention to Reduce Methamphetamine Use
NCT04713124 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204
Last updated 2025-08-07
Summary
Australia has one of the highest rates of methamphetamine use in the world; however, uptake of face-to-face psychological treatment remains extremely low due to numerous individual (e.g. stigma, shame) and structural (e.g. service availability, geography) barriers to accessing care. Addressing these barriers through the provision of alternative treatment delivery models is imperative, particularly as effective and earlier intervention is likely to reduce the need for more costly and intensive treatment resulting from escalating methamphetamine use.
In this project, the investigators will conduct the first double-blind, parallel-group, randomised controlled trial (RCT) examining the effectiveness of the structured telephone-delivered intervention, Ready2Change (R2C), among participants with methamphetamine use problems (R2C-M). Cost effectiveness of R2C-M will also be investigated. Factors influencing program implementation will be evaluated to inform the scalability of this intervention for practice nationally, and for replication internationally.
Conditions
- Methamphetamine Use Disorder
Interventions
- BEHAVIORAL
-
R2C-M
R2C-M comprises 12 modules addressing core practice elements and skills from evidence-based cognitive and behavioural interventions. Modules include: (i) self-monitoring, goal setting and behaviour change skills; (ii) identification of strengths and motivational enhancement; (iii) relapse prevention; (iv) psychoeducation and harm reduction; (v) emotion regulation skills; (vi) anger management skills; (vii) urges and cravings management skills; (viii) sleep hygiene skills; (ix) mindfulness skills; (x) interpersonal skills; (xi) anxiety management skills; (xii) depressed mood management skills. The R2C-M workbooks contain psychoeducation and intervention exercises, to facilitate counsellor-delivered exercises within sessions, and between-session practice.
- OTHER
-
Self-help booklet
A booklet of information and self-help strategies for methamphetamine use problems.
Sponsors & Collaborators
-
Eastern Health
collaborator OTHER - collaborator OTHER
-
Deakin University
collaborator OTHER -
Turning Point
lead OTHER
Principal Investigators
-
Dan I Lubman · Turning Point, Eastern Health; Monash University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-04
- Primary Completion
- 2023-05-01
- Completion
- 2024-01-25
Countries
- Australia
Study Locations
More Related Trials
-
Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.
NCT04531384 ·Status: UNKNOWN ·Phase: NA
-
Rivastigmine as a Treatment for Methamphetamine Dependence
NCT01073319 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
NCT00630682 ·Status: COMPLETED ·Phase: PHASE2
-
Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder
NCT05550493 ·Status: COMPLETED ·Phase: NA
-
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
NCT00687713 ·Status: COMPLETED ·Phase: PHASE2
-
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
NCT02896712 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
NCT06538285 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Trial of Modafinil for Methamphetamine Dependence
NCT00123370 ·Status: UNKNOWN ·Phase: PHASE2
-
RTI-336 as a Treatment for Methamphetamine Dependence
NCT01601717 ·Status: WITHDRAWN ·Phase: PHASE1
-
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
NCT01011829 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
NCT05266716 ·Status: COMPLETED ·Phase: NA
-
Mood and Decision-making in Methamphetamine Use Disorder
NCT06410196 ·Status: RECRUITING ·Phase: NA
-
Modafinil for Methamphetamine Dependence
NCT00859573 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence
NCT02034201 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence
NCT00520286 ·Status: COMPLETED ·Phase: PHASE2
-
Gamified Adaptive Approach Bias Modification on Individuals With Methamphetamine Use History
NCT05794438 ·Status: COMPLETED ·Phase: NA
-
Flupenthixol Decanoate in Methamphetamine Smoking - 1
NCT00000241 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Modafinil in Methamphetamine Dependence
NCT00751023 ·Status: COMPLETED ·Phase: PHASE4
-
A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1
NCT00033124 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2
NCT00135785 ·Status: COMPLETED ·Phase: PHASE2
-
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)
NCT01888835 ·Status: COMPLETED ·Phase: PHASE2
-
Prometa Pharmacotherapy for Methamphetamine Dependence
NCT00260481 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Methamphetamine Abuse Treatment in Patients With AIDS - 1
NCT00000321 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Ch-mAb7F9 for Methamphetamine Abuse
NCT01603147 ·Status: COMPLETED ·Phase: PHASE1